Charles River Laboratories Current Ratio 2010-2024 | CRL

Current and historical current ratio for Charles River Laboratories (CRL) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Charles River Laboratories current ratio for the three months ending March 31, 2024 was 1.75.
Charles River Laboratories Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-03-31 $1.67B $0.96B 1.75
2023-12-31 $1.61B $1.06B 1.53
2023-09-30 $1.44B $0.99B 1.45
2023-06-30 $1.51B $1.01B 1.49
2023-03-31 $1.45B $0.98B 1.48
2022-12-31 $1.44B $1.09B 1.32
2022-09-30 $1.42B $1.01B 1.40
2022-06-30 $1.39B $1.05B 1.33
2022-03-31 $1.33B $0.99B 1.34
2021-12-31 $1.27B $1.03B 1.23
2021-09-30 $1.38B $0.98B 1.40
2021-06-30 $1.27B $0.93B 1.36
2021-03-31 $1.42B $0.80B 1.77
2020-12-31 $1.20B $0.84B 1.43
2020-09-30 $1.14B $0.79B 1.45
2020-06-30 $1.24B $0.73B 1.70
2020-03-31 $1.21B $0.69B 1.75
2019-12-31 $1.02B $0.71B 1.44
2019-09-30 $0.97B $0.68B 1.43
2019-06-30 $1.01B $0.64B 1.59
2019-03-31 $0.87B $0.53B 1.64
2018-12-31 $0.90B $0.56B 1.61
2018-09-30 $0.84B $0.54B 1.55
2018-06-30 $0.89B $0.52B 1.72
2018-03-31 $0.84B $0.41B 2.07
2017-12-31 $0.83B $0.46B 1.78
2017-09-30 $0.78B $0.42B 1.88
2017-06-30 $0.74B $0.42B 1.74
2017-03-31 $0.70B $0.38B 1.83
2016-12-31 $0.66B $0.43B 1.53
2016-09-30 $0.66B $0.41B 1.59
2016-06-30 $0.70B $0.41B 1.70
2016-03-31 $0.64B $0.31B 2.06
2015-12-31 $0.56B $0.31B 1.79
2015-09-30 $0.58B $0.31B 1.84
2015-06-30 $0.63B $0.28B 2.28
2015-03-31 $0.61B $0.27B 2.27
2014-12-31 $0.58B $0.30B 1.97
2014-09-30 $0.61B $0.28B 2.14
2014-06-30 $0.59B $0.27B 2.18
2014-03-31 $0.59B $0.24B 2.47
2013-12-31 $0.55B $0.25B 2.24
2013-09-30 $0.55B $0.24B 2.33
2013-06-30 $0.52B $0.23B 2.30
2013-03-31 $0.49B $0.33B 1.49
2012-12-31 $0.49B $0.34B 1.42
2012-09-30 $0.46B $0.33B 1.41
2012-06-30 $0.45B $0.33B 1.38
2012-03-31 $0.44B $0.22B 1.95
2011-12-31 $0.43B $0.22B 1.96
2011-09-30 $0.46B $0.22B 2.04
2011-06-30 $0.55B $0.28B 1.98
2011-03-31 $0.56B $0.31B 1.82
2010-12-31 $0.55B $0.26B 2.13
2010-09-30 $0.53B $0.24B 2.22
2010-06-30 $0.61B $0.25B 2.47
2010-03-31 $0.61B $0.25B 2.48
2009-12-31 $0.60B $0.25B 2.39
2009-09-30 $0.57B $0.25B 2.23
2009-06-30 $0.57B $0.27B 2.11
2009-03-31 $0.58B $0.28B 2.08
Sector Industry Market Cap Revenue
Medical Medical Services $10.900B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $124.209B 15.59
Cencora (COR) United States $47.206B 18.40
ICON (ICLR) Ireland $26.298B 24.83
DiDi Global (DIDIY) China $21.580B 0.00
Avantor (AVTR) United States $15.025B 22.12
CochLear (CHEOY) Australia $14.104B 0.00
Revvity (RVTY) United States $13.324B 23.37
Natera (NTRA) United States $13.153B 0.00
Medpace Holdings (MEDP) United States $12.518B 41.19
Viatris (VTRS) United States $12.466B 3.73
EUROFINS SCIENT (ERFSF) Luxembourg $10.906B 0.00
Solventum (SOLV) United States $9.041B 0.00
Sonic Healthcare (SKHHY) Australia $8.666B 0.00
HealthEquity (HQY) United States $7.278B 46.73
Organon (OGN) United States $5.359B 5.08
Bausch + Lomb (BLCO) Canada $5.253B 21.03
Doximity (DOCS) United States $5.103B 35.74
PACS (PACS) United States $4.437B 0.00
Life Times (LTH) United States $3.659B 38.33
Sotera Health (SHC) United States $3.400B 16.68
Surgery Partners (SGRY) United States $3.113B 28.48
GoodRx Holdings (GDRX) United States $2.900B 110.43
Agilon Health (AGL) United States $2.681B 0.00
Progyny (PGNY) United States $2.462B 42.39
NovoCure (NVCR) Jersey $2.052B 0.00
AMN Healthcare Services Inc (AMN) United States $2.013B 7.98
Premier (PINC) United States $1.950B 8.34
BrightSpring Health Services (BTSG) United States $1.819B 0.00
Teladoc Health (TDOC) United States $1.647B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.566B 0.00
Alignment Healthcare (ALHC) United States $1.388B 0.00
Establishment Labs Holdings (ESTA) $1.141B 0.00
CareDx (CDNA) United States $0.732B 0.00
Embecta (EMBC) United States $0.721B 4.91
GeneDx Holdings (WGS) United States $0.717B 0.00
Pediatrix Medical (MD) United States $0.673B 7.14
InnovAge Holding (INNV) United States $0.646B 0.00
Auna S.A (AUNA) Luxembourg $0.599B 0.00
Sharecare (SHCR) United States $0.497B 0.00
QDM (QDMI) Hong Kong, SAR China $0.437B 11.45
Enhabit (EHAB) United States $0.428B 42.70
COMPASS Pathways (CMPS) United Kingdom $0.427B 0.00
Sonida Senior Living (SNDA) United States $0.370B 0.00
ModivCare (MODV) United States $0.368B 6.88
DocGo (DCGO) United States $0.314B 17.17
LifeMD (LFMD) United States $0.289B 0.00
MultiPlan (MPLN) United States $0.236B 0.00
Beauty Health (SKIN) United States $0.221B 0.00
Sera Prognostics (SERA) United States $0.217B 0.00
Biodesix (BDSX) United States $0.196B 0.00
Ascend Wellness Holdings (AAWH) United States $0.189B 0.00
So-Young (SY) China $0.108B 52.00
Pono Capital Two (PTWO) United States $0.068B 0.00
Co-Diagnostics (CODX) United States $0.046B 0.00
NeueHealth (NEUE) United States $0.042B 5.72
IceCure Medical (ICCM) Israel $0.034B 0.00
Oncology Institute (TOI) United States $0.033B 0.00
Nutex Health (NUTX) United States $0.028B 0.00
Singular Genomics Systems (OMIC) United States $0.026B 0.00
OncoCyte (OCX) United States $0.023B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
SeaStar Medical Holding (ICU) United States $0.022B 0.00
KindlyMD (KDLY) $0.017B 0.00
BIMI Holdings (BIMI) United States $0.015B 0.00
TRxADE HEALTH (MEDS) United States $0.013B 0.00
BioNexus Gene Lab (BGLC) $0.008B 0.00
XWELL (XWEL) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
ISpecimen (ISPC) United States $0.005B 0.00
DermTech (DMTK) United States $0.004B 0.00
NewGenIvf Group (NIVF) Singapore $0.004B 0.00
OpGen (OPGN) United States $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Assure Holdings (IONM) United States $0.002B 0.00